Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Mar 28;9:843640. doi: 10.3389/fmolb.2022.843640

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Guo, Li, Xu, Xu, Wang, Li, Bi, Cao, Xu, Xia, Cui and Li.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

CRDC-related immune infiltration characteristics. (A) Spearman correlation analysis plot of the correlativity of the CRDC score, StromalScore, ImmuneScore, ESTIMATEScore, TumorPurity, TMB, and CYT. Boxplots described the expression difference of (B) PD-L1, (C) PD-1, and (D) CTLA4 between CRDC-High and CRDC-Low samples. (E) Spearman correlation heatmap of CRDC genes and immune microenvironment cell infiltration, StromalScore, ImmuneScore, ESTIMATEScore, TumorPurity, TMB, CIN, CYT, PD-L1, PD-1, and CTLA4. (F,G) Immune microenvironment cell infiltration level in CRDC-High and CRDC-Low samples. The violin plots displayed the TIDE (H) and IPS (I) scores between CRDC-High and -Low groups. (J) Heatmap of comparison and identification of common subtypes between groups divided by CRDC risk and response for ICB therapy. NR and R represented not respond and respond to immunotherapy, respectively.